Target RWE, a leader in real-world evidence solutions in liver disease, presented important research on the use of ...

Weight loss medications like Ozempic, Wegovy, and Mounjaro are not only effective in curbing appetite but also in reducing ...

While surgery has a low risk for complications, when they do occur, they are serious. This may explain why only 5%-10% of ...

In a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of ...

About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 (GLP-1) receptor agonists and GLP-1/glucose-dependent insulinotropic polypeptide ...

Presentations at the 2024 Asembia Specialty Pharmacy Summit focused on reshaping specialty pharmacy while keeping patients ...

Some of what RFK Jr. says about obesity prevention isn't new. But after having coined the catchy MAHA acronym, it’s likely ...

Medically reviewed by Peter Weiss, MD Ozempic is the brand name of a medication called semaglutide, a glucagon-like peptide-1 ...

Semaglutide, a GLP-1 agonist, has been widely studied due to its versatility, efficacy, and ability to address multiple ...

The investment landscape has transformed since the presidential election, with small-cap stocks gaining momentum. The Russell ...

BioNxt Solutions announces development of sublingual thin-film ODF for Semaglutide: Vancouver, BC Tuesday, December 3, 2024, 17:00 Hrs [IST] BioNxt Solutions Inc., a bioscience co ...

A study finds that anti-obesity medications may help reduce alcohol consumption, with nearly half of participants in weight ...